Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies

[1]  D. Schadendorf,et al.  Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study , 2012, Pigment cell & melanoma research.

[2]  N. Hayward,et al.  Melanocortin 1 receptor and risk of cutaneous melanoma: A meta‐analysis and estimates of population burden , 2011, International journal of cancer.

[3]  John P A Ioannidis,et al.  Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. , 2011, Journal of the National Cancer Institute.

[4]  Yurii B. Shvetsov,et al.  Estrogen Receptor Beta rs1271572 Polymorphism and Invasive Ovarian Carcinoma Risk: Pooled Analysis within the Ovarian Cancer Association Consortium , 2011, PloS one.

[5]  Josée Dupuis,et al.  Meta‐analysis of gene‐environment interaction: joint estimation of SNP and SNP × environment regression coefficients , 2011, Genetic epidemiology.

[6]  Paul Brennan,et al.  Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. , 2010, Journal of the National Cancer Institute.

[7]  I. Jackson,et al.  The physiological and phenotypic determinants of human tanning measured as change in skin colour following a single dose of ultraviolet B radiation , 2010, Experimental dermatology.

[8]  D. Elder,et al.  Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? , 2010, Cancer.

[9]  Stephen Kaptoge,et al.  Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies , 2010, International journal of epidemiology.

[10]  Laurence Ambroisine,et al.  Functional MC1R-gene variants are associated with increased risk for severe photoaging of facial skin. , 2010, The Journal of investigative dermatology.

[11]  E. Halperin,et al.  Chemokine polymorphisms and lymphoma: a pooled analysis , 2010, Leukemia & lymphoma.

[12]  D. Duffy,et al.  Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. , 2010, The Journal of investigative dermatology.

[13]  N. Hayward,et al.  The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population. , 2010, The Journal of investigative dermatology.

[14]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[15]  Andrea Parisi,et al.  Theoretical Epidemiology , 2010 .

[16]  F. Gruber,et al.  MC1R Gene Polymorphism Affects Skin Color and Phenotypic Features Related to Sun Sensitivity in a Population of French Adult Women , 2009, Photochemistry and photobiology.

[17]  D. Schadendorf,et al.  Melanocortin receptor 1 variants and melanoma risk: A study of 2 European populations , 2009, International journal of cancer.

[18]  P. Ascierto,et al.  Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy , 2009, BMC Cancer.

[19]  M. von Knebel Doeberitz,et al.  TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. , 2009, The Lancet. Oncology.

[20]  C. Cybulski,et al.  Vitamin D receptor variants and the malignant melanoma risk: a population-based study. , 2009, Cancer epidemiology.

[21]  A. Scope,et al.  MC1R variant alleles and malignant melanoma risk in Israel. , 2009, European journal of cancer.

[22]  William P. Neace,et al.  Genetic variations associated with red hair color and fear of dental pain, anxiety regarding dental care and avoidance of dental care. , 2009, Journal of the American Dental Association.

[23]  R. Talamini,et al.  CDKN2A and MC1R analysis in amelanotic and pigmented melanoma , 2009, Melanoma research.

[24]  A. Bowcock,et al.  Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients , 2009, Experimental dermatology.

[25]  J. Lundeberg,et al.  MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters , 2009, Pigment cell & melanoma research.

[26]  A. Cecile J.W. Janssens,et al.  Eye color and the prediction of complex phenotypes from genotypes , 2009, Current Biology.

[27]  Anna Wojas-Pelc,et al.  Interactions Between HERC2, OCA2 and MC1R May Influence Human Pigmentation Phenotype , 2009, Annals of human genetics.

[28]  H Tunstall-Pedoe,et al.  Systematically missing confounders in individual participant data meta-analysis of observational cohort studies , 2009, Statistics in medicine.

[29]  W. Branicki,et al.  The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population , 2009, Experimental dermatology.

[30]  H. Gogas,et al.  A study of a single variant allele (rs1426654) of the pigmentation‐related gene SLC24A5 in Greek subjects , 2009, Experimental dermatology.

[31]  D. Hunter,et al.  Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians , 2009, International journal of cancer.

[32]  H. Eiberg,et al.  Determination of cis/trans phase of variations in the MC1R gene with allele‐specific PCR and single base extension , 2008, Electrophoresis.

[33]  P. Queirolo,et al.  CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma , 2008, Pigment cell & melanoma research.

[34]  F. Claverie-Martin,et al.  The D84E variant of the alpha-MSH receptor 1 gene is associated with cutaneous malignant melanoma early onset. , 2008, Journal of dermatological science.

[35]  D. Elder,et al.  MC1R variants increase risk of melanomas harboring BRAF mutations. , 2008, The Journal of investigative dermatology.

[36]  B. Prum,et al.  Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population , 2008, Human mutation.

[37]  F. Claverie-Martin,et al.  Main pigmentary features and melanocortin 1 receptor (MC1R) gene polymorphisms in the population of the Canary Islands , 2008, International journal of dermatology.

[38]  D. Duffy,et al.  Red hair is the null phenotype of MC1R , 2008, Human mutation.

[39]  D. Hunter,et al.  Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk , 2008, The British journal of dermatology.

[40]  D. Schadendorf,et al.  Melanocortin receptor 1 variants and melanoma risk – a study on two European populations , 2008 .

[41]  F. Sera,et al.  MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.

[42]  T. Katagiri,et al.  Polymorphism patterns in the promoter region of the MC1R gene are associated with development of freckles and solar lentigines. , 2008, The Journal of investigative dermatology.

[43]  D. Duffy,et al.  Spectrophotometric Methods for Quantifying Pigmentation in Human Hair—Influence of MC1R Genotype and Environment , 2008, Photochemistry and photobiology.

[44]  Takashi Abe,et al.  Interactions between SNP Alleles at Multiple Loci Contribute to Skin Color Differences between Caucasoid and Mongoloid Subjects , 2008, International journal of biological sciences.

[45]  K. Hemminki,et al.  MC1R variants associated susceptibility to basal cell carcinoma of skin: Interaction with host factors and XRCC3 polymorphism , 2007, International journal of cancer.

[46]  Holger Schwender,et al.  Identification of SNP interactions using logic regression. , 2008, Biostatistics.

[47]  D. Duffy,et al.  Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. , 2007, Human molecular genetics.

[48]  V. Goel,et al.  Interactions Between SNP Alleles at Multiple Loci and Variation in Skin Pigmentation in 122 Caucasians , 2007, Evolutionary bioinformatics online.

[49]  J. Benítez,et al.  MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population. , 2007, Carcinogenesis.

[50]  T. Katagiri,et al.  Effect of Val92Met and Arg163Gln variants of the MC1R gene on freckles and solar lentigines in Japanese. , 2007, Pigment cell research.

[51]  T. Kupiec,et al.  Determination of Phenotype Associated SNPs in the MC1R Gene * , 2007, Journal of forensic sciences.

[52]  Paolo Boffetta,et al.  Consortia in Cancer Epidemiology: Lessons from InterLymph , 2007, Cancer Epidemiology Biomarkers & Prevention.

[53]  H. Gogas,et al.  p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants , 2007, The British journal of dermatology.

[54]  John P. A. Ioannidis,et al.  The Emergence of Networks in Human Genome Epidemiology: Challenges and Opportunities , 2007, Epidemiology.

[55]  I. Gram,et al.  Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review. , 2006, American journal of epidemiology.

[56]  J. Kładny,et al.  MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk , 2006, International journal of cancer.

[57]  M. Spitz,et al.  Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. , 2006, American journal of epidemiology.

[58]  C. Berking,et al.  Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma , 2006, Archives of Dermatological Research.

[59]  G. Colditz,et al.  Melanocortin 1 receptor variants and skin cancer risk , 2006, International journal of cancer.

[60]  R. Millikan,et al.  Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. , 2006, Cancer research.

[61]  A. Goldstein,et al.  Comprehensive evaluation of allele frequency differences of MC1R variants across populations. , 2006, Human mutation.

[62]  H. Gogas,et al.  Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. , 2006, The Journal of investigative dermatology.

[63]  C. Lebbé,et al.  MC1R and PTCH gene polymorphism in French patients with basal cell carcinomas. , 2006, The Journal of investigative dermatology.

[64]  Vittorio Krogh,et al.  Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. , 2006, American journal of epidemiology.

[65]  H. Höfler,et al.  Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case–control study , 2006, Melanoma research.

[66]  P. Carli,et al.  Re: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. , 2006, Journal of the National Cancer Institute.

[67]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. , 2005, European journal of cancer.

[68]  F. Clerget-Darpoux,et al.  Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma , 2005, European Journal of Human Genetics.

[69]  Maria Teresa Landi,et al.  MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. , 2005, Journal of the National Cancer Institute.

[70]  A. L. Kadekaro,et al.  MC1R and the response of melanocytes to ultraviolet radiation. , 2005, Mutation research.

[71]  Ingo Ruczinski,et al.  Identifying interacting SNPs using Monte Carlo logic regression , 2005, Genetic epidemiology.

[72]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.

[73]  Clifton R. Lacy.  Health emergency and disaster preparedness initiatives of the New Jersey Department of Health and Senior Services. , 2004, New Jersey medicine : the journal of the Medical Society of New Jersey.

[74]  R. Sturm,et al.  Novel MC1R variants in Ligurian melanoma patients and controls , 2004, Human mutation.

[75]  D. Guerry,et al.  Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[76]  T. Dwyer,et al.  Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? , 2004, American journal of epidemiology.

[77]  Shosuke Ito,et al.  Quantitative measures of the effect of the melanocortin 1 receptor on human pigmentary status. , 2004, The Journal of investigative dermatology.

[78]  C. Lebbé,et al.  Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure , 2004, Journal of Medical Genetics.

[79]  Wei Chen,et al.  Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. , 2003, Human molecular genetics.

[80]  M. LeBlanc,et al.  Logic Regression , 2003 .

[81]  H. Höfler,et al.  Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population , 2003, Human mutation.

[82]  Li Jin,et al.  Skin pigmentation, biogeographical ancestry and admixture mapping , 2003, Human Genetics.

[83]  John P A Ioannidis,et al.  Commentary: meta-analysis of individual participants' data in genetic epidemiology. , 2002, American journal of epidemiology.

[84]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[85]  T. Dwyer.  The Menzies Centre for Population Health Research , 2001, The Medical journal of Australia.

[86]  S. Germer,et al.  Thr40 and Met122 are new partial loss‐of‐function natural mutations of the human melanocortin 1 receptor , 2001, FEBS letters.

[87]  H. Ullum,et al.  Effects of CCR5- 32, CCR2-64I, and SDF-1 3A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data , 2001, Annals of Internal Medicine.

[88]  R. Willemze,et al.  Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. , 2001, The Journal of investigative dermatology.

[89]  R. Westendorp,et al.  The melanocortin-1-receptor gene is the major freckle gene. , 2001, Human molecular genetics.

[90]  A. van Daal,et al.  A polymorphism study of the human Agouti gene and its association with MC1R. , 2001, Pigment cell research.

[91]  E Demidenko,et al.  Two‐stage methods for the analysis of pooled data , 2001, Statistics in medicine.

[92]  M. Xiong,et al.  Interaction between the melanocortin-1 receptor andP genes contributes to inter-individual variation in skin pigmentation phenotypes in a Tibetan population , 2001, Human Genetics.

[93]  R. Strange,et al.  Genetic factors determining cutaneous basal cell carcinoma phenotype. , 2001, Medical and pediatric oncology.

[94]  R. Westendorp,et al.  Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. , 2001, American journal of human genetics.

[95]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[96]  M. Daly,et al.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.

[97]  D. Duffy,et al.  Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. , 2001, The Journal of investigative dermatology.

[98]  H. Ullum,et al.  Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. , 2001, Annals of internal medicine.

[99]  C Kooperberg,et al.  Sequence Analysis Using Logic Regression , 2001, Genetic epidemiology.

[100]  H Goldstein,et al.  A multilevel model framework for meta-analysis of clinical trials with binary outcomes. , 2000, Statistics in medicine.

[101]  I. Jackson,et al.  Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. , 2000, Human molecular genetics.

[102]  I. Jackson,et al.  Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair , 2000, The Lancet.

[103]  D. Duffy,et al.  Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? , 2000, American journal of human genetics.

[104]  M Huberman,et al.  Application of the missing-indicator method in matched case-control studies with incomplete data. , 1999, American journal of epidemiology.

[105]  J. Lear,et al.  Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci. , 1999, Carcinogenesis.

[106]  J. Lear,et al.  Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma. , 1999, Pharmacogenetics.

[107]  J H Lubin,et al.  Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. , 1999, American journal of epidemiology.

[108]  W. Ollier,et al.  The melanocyte stimulating hormone receptor polymorphism: association of the V92M and A294H alleles with basal cell carcinoma. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[109]  D. Hewett‐Emmett,et al.  High polymorphism at the human melanocortin 1 receptor locus. , 1999, Genetics.

[110]  W. Thomson,et al.  Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. , 1998, The Journal of investigative dermatology.

[111]  I. Jackson,et al.  Melanocortin 1 receptor variants in an Irish population. , 1998, The Journal of investigative dermatology.

[112]  N. Martin,et al.  Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. , 1997, Human molecular genetics.

[113]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[114]  I. Jackson,et al.  The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. , 1996, Human molecular genetics.

[115]  Ian Jackson,et al.  Variants of the melanocyte–stimulating hormone receptor gene are associated with red hair and fair skin in humans , 1995, Nature Genetics.

[116]  L. Excoffier,et al.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.

[117]  K. Kidd,et al.  HAPLO: a program using the EM algorithm to estimate the frequencies of multi-site haplotypes. , 1995, The Journal of heredity.

[118]  S. Ito,et al.  Effects of melanocyte-stimulating hormone on tyrosinase expression and melanin synthesis in hair follicular melanocytes of the mouse. , 1993, The Journal of endocrinology.

[119]  Robert M. Sayre,et al.  New trends in photobiology: Photoprotection by melanin , 1991 .

[120]  N Kollias,et al.  Photoprotection by melanin. , 1991, Journal of photochemistry and photobiology. B, Biology.

[121]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[122]  N. Breslow,et al.  The analysis of case-control studies , 1980 .